Adiponectin: A Predictor for Breast Cancer Survival?
Hikmet Erhan GüvenLutfi DoganMehmet Ali GülçelikNeşe Ersöz GülçelikPublished in: European journal of breast health (2018)
Preoperative adiponectin levels may be useful to predict survival rates in breast cancer or may be used as a marker/predictor for defining patients who require more aggressive treatment. In order for adiponectin to be used as a practical clinical marker for breast cancer, large database studies are should be conducted.